Calmare Therapeutics (CTTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-1997 | 09-1997 | 06-1997 | 03-1997 | 12-1996 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -500 | N/A | N/A | N/A | -588 |
| Depreciation Amortization | 150 | N/A | N/A | N/A | 330 |
| Other Working Capital | -470 | N/A | N/A | N/A | -981 |
| Other Operating Activity | 150 | 0 | 0 | 0 | 11 |
| Operating Cash Flow | $-670 | $N/A | $N/A | $N/A | $-1,228 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -20 | N/A | N/A | N/A | -54 |
| Net Acquisitions | 0 | N/A | N/A | N/A | 105 |
| Other Investing Activity | 390 | 0 | 0 | 0 | 946 |
| Investing Cash Flow | $370 | $N/A | $N/A | $N/A | $997 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | -370 | 0 | 0 | 0 | 456 |
| Financing Cash Flow | $-370 | $N/A | $N/A | $N/A | $456 |
| Beginning Cash Position | 930 | N/A | N/A | N/A | 336 |
| End Cash Position | 260 | N/A | N/A | N/A | 560 |
| Net Cash Flow | $-670 | $N/A | $N/A | $N/A | $224 |
| Free Cash Flow | |||||
| Operating Cash Flow | -670 | N/A | N/A | N/A | -1,228 |
| Free Cash Flow | -670 | 0 | 0 | 0 | -1,228 |